医院脓毒症病例量与循证诊疗流程依从性及患者结局的关系
该回顾性队列研究利用美国534家医院的行政数据,纳入2010年7月至2012年12月入院时即存在脓毒症的287,914例成人患者,其中58,045例在住院前2天因脓毒性休克接受升压药治疗。研究分析脓毒症病例量与三项循证流程(住院首日测量乳酸、去甲肾上腺素作为首选升压药、避免淀粉基胶体)的关联,并评估其在病例量-死亡率关联中的中介作用。结果显示,最高病例量医院更可能测量乳酸(调整OR 2.8,95%CI 2.1-3.7)和以去甲肾上腺素为首选升压药(调整OR 2.1,95%CI 1.6-2.7),但避免淀粉与病例量无关(调整OR 0.73,95%CI 0.45-1.2);依从循证诊疗与较低住院死亡率相关(调整OR 0.81,95%CI 0.70-0.94),但并未强烈中介病例量-死亡率关联(点估计变化≤2%)。作者认为,在区域化脓毒症救治时同时考虑流程和病例量可能最大化患者结局。
要点
- 在287,914例脓毒症患者中,1.9%接受了淀粉基胶体;在58,045例脓毒性休克患者中,68.3%测量了乳酸,64%以去甲肾上腺素作为初始升压药。
- 最高病例量医院(第4四分位 vs 第1四分位)更可能测量乳酸(调整OR 2.8,95%CI 2.1-3.7)和以去甲肾上腺素为首选升压药(调整OR 2.1,95%CI 1.6-2.7)。
- 病例量与避免淀粉产品无关(调整OR 0.73,95%CI 0.45-1.2)。
- 依从循证诊疗与较低住院死亡率相关(调整OR 0.81,95%CI 0.70-0.94),但并未强烈中介病例量-死亡率关联(点估计变化≤2%)。
- 作者认为,在区域化脓毒症救治时同时考虑流程和病例量可能最大化患者结局。
适用人群与场景
- 2010年7月至2012年12月期间入院时即存在脓毒症的成人患者,共287,914例,来自美国534家医院。
- 其中58,045例在住院前2天因脓毒性休克接受升压药治疗。
研究设计与关键结果
- 研究类型为回顾性队列研究,利用美国534家医院的增强行政数据(Premier,Charlotte,NC),纳入287,914例入院时即存在脓毒症的成人患者,其中58,045例在住院前2天因脓毒性休克接受升压药。
- 在脓毒症患者中,1.9%接受了淀粉基胶体;在脓毒性休克患者中,68.3%测量了乳酸,64%以去甲肾上腺素作为初始升压药。
- 最高病例量医院(第4四分位 vs 第1四分位)更可能测量乳酸(调整OR 2.8,95%CI 2.1-3.7)和以去甲肾上腺素为首选升压药(调整OR 2.1,95%CI 1.6-2.7)。
- 病例量与避免淀粉产品无关(调整OR 0.73,95%CI 0.45-1.2)。
- 依从循证诊疗与较低住院死亡率相关(调整OR 0.81,95%CI 0.70-0.94),但并未强烈中介病例量-死亡率关联(点估计变化≤2%)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在区域化脓毒症救治时同时考虑流程和病例量可能最大化患者结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We sought to explore potential mechanisms underlying hospital sepsis case volume-mortality associations by investigating implementation of evidence-based processes of care.
DESIGN: Retrospective cohort study. We determined associations of sepsis case volume with three evidence-based processes of care (lactate measurement during first hospital day, norepinephrine as first vasopressor, and avoidance of starch-based colloids) and assessed their role in mediation of case volume-mortality associations.
SETTING: Enhanced administrative data (Premier, Charlotte, NC) from 534 U.S. hospitals.
SUBJECTS: A total of 287,914 adult patients with sepsis present at admission between July 2010 and December 2012 of whom 58,045 received a vasopressor for septic shock during the first 2 days of hospitalization.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among patients with sepsis, 1.9% received starch, and among patients with septic shock, 68.3% had lactate measured and 64% received norepinephrine as initial vasopressor. Patients at hospitals with the highest case volume were more likely to have lactate measured (adjusted odds ratio quartile 4 vs quartile 1, 2.8; 95% CI, 2.1-3.7) and receive norepinephrine as initial vasopressor (adjusted odds ratio quartile 4 vs quartile 1, 2.1; 95% CI, 1.6-2.7). Case volume was not associated with avoidance of starch products (adjusted odds ratio quartile 4 vs quartile 1, 0.73; 95% CI, 0.45-1.2). Adherence to evidence-based care was associated with lower hospital mortality (adjusted odds ratio, 0.81; 95% CI, 0.70-0.94) but did not strongly mediate case volume-mortality associations (point estimate change ≤ 2%).
CONCLUSIONS: In a large cohort of U.S. patients with sepsis, select evidence-based processes of care were more likely implemented at high-volume hospitals but did not strongly mediate case volume-mortality associations. Considering processes and case volume when regionalizing sepsis care may maximize patient outcomes.
参考来源
- Fawzy A, Walkey AJ. Association Between Hospital Case Volume of Sepsis, Adherence to Evidence-Based Processes of Care and Patient Outcomes. Crit Care Med. 2017. PMID: 28350646. doi:10.1097/CCM.0000000000002409
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。